HTB

Coinfections and complications

opportunistic infections, coinfections and complications

BHIVA recommendations on measles in the UK

BHIVA update guidance on shingles vaccine

HIV guidelines recommend a statin for all people older than 40: new BHIVA document

Timing of ART with cryptococcus: Europe and the US cohort data challenged by African RCT data and editorial comment

Peripheral inflammation linked to structural brain changes and reduced blood flow despite suppressive ART

ART-associated hypertension can be successfully treated in African settings

REPRIEVE study: statin benefits people living with HIV at low to moderate CVD risk

New UK vaccine schedule for HPV depends on HIV status

UK shingles vaccine: changes from 1 September 2023

New guidelines on cognitive impairment in people living with HIV

BHIVA guidelines on non-TB mycobacteria (NTM)

No benefit on HIV-associated neurocognitive impairment from CNS-penetrating ART

First successful liver transplant from living donor with HIV/HCV coinfection: surgical video online

Review of idiopathic lymphocytopenia

Statins reduce heart disease by 35% in the international HIV REPRIEVE study

Penile BOTOX injections improve blood flow and other outcomes in men with moderate to severe erectile dysfunction

CROI 2023: Single dose doxycycline as PEP for STIs (DoxyPEP): five studies

Superinfection detected in up to 7% of people in Swiss HIV Cohort Study

Potential to use BOTOX for erectile dysfunction

Cases of Kaposi’s Sarcoma (KS) in people on effective ART

Shorter course of less-intensive treatment for visceral leishmaniasis

Reduced HAND prevalence in large cross-sectional cohort study  

Understanding HIV and monkeypox coinfection: NEAT/EACS dashboard

BHIVA include efficacy data on HIV and monkeypox vaccine: updated statement

Doxycycline PEP significantly reduces STIs in people at high risk of infections

WHO declares the monkeypox pandemic a global health emergency

UK organisations call for £51 million to urgently tackle monkeypox crisis

EMA approves Imvanex vaccine against monkeypox in EU

International study of 528 monkeypox (MPX) cases: results from the 2022 outbreak need to inform new management guidelines

Monkeypox DNA detected at high levels in saliva and is common in semen and other samples

Risk of monkeypox being infectious on hard surfaces and soft materials: guidelines for effective cleaning

Outcomes of 54 cases of monkeypox (MPX) in London: fewer early symptoms but higher rates of genital lesions – urgency of funding sexual health

Ending the monkeypox outbreak through vaccination, contact tracing and early diagnosis

Case report of COVID-19 transmission from sneezing cat

Accumulating SARS-CoV-2 mutations in prolonged COVID-19 in advanced HIV off-ART

No benefit from TDF/FTC against COVID-19

Monkeypox crisis in the UK needs urgent funding: sex, vaccines and Pride

UK offers limited vaccine to gay and bisexual men at risk of monkeypox: full dose offered in NYC

Gonorrhoea vaccine might halve infections and help combat drug resistance

COVID update: new waves of BA.4 and BA.5 in the UK – all omicron variants linked to reduced antibody responses to vaccines

Importance of booster vaccine to protect against emergent COVID-19 variants

Similar COVID-19 vaccination responses in HIV positive people on ART and with good CD4 counts compared to HIV negative controls

US study reports higher rates of breakthrough COVID in HIV positive vs negative controls

BMJ reports UK government failed to protect doctors during COVID-19

Monkeypox outbreak: Update and further information

Monkeypox cases in gay men in the UK: BHIVA and ECDC rapid statements

Monkeypox DNA in semen supports advice to use condoms for eight weeks after infection has cleared

Risk of monkeypox becoming endemic in Europe: ECDC assessment

Seven cases of monkeypox virus in the UK from 2018 to 2021

Monkeypox: Q&A factsheet

CROI 2022: Other COVID-19 studies

Asymptomatic COVID-19 is common in people living with HIV

Longest COVID-19 infection lasted 505 days in an immunocompromised person in London

Herd immunity unlikely to control COVID-19: opinion article from US NIAID

The challenges of prioritising access to molnupiravir and nirmatrelvir–ritonavir for COVID-19

Increased risk of blood clots after COVID-19: higher with underlying conditions and more severe symptoms

Two new platform vaccines against COVID-19 report phase 3 results

CROI 2022: UK study reports diabetes mellitus in 9% of HIV positive Africans in the UK on stable ART

CROI 2022: Life expectancy reduced by eight years following hospitalisation for a mental health condition in South Africa

CROI 2022: Long COVID persists for over a year: evidence for divergent immune responses

CROI 2022: Risk factors for NAFLD and proteinuria in HIV positive people on ART in the REPRIEVE study

Timing of menopause: experiences of women in Swiss HIV Cohort

HIV-associated reductions in telomere length are stopped by effective ART

The importance of confirming screening test results for diabetes and hypertension

ECG abnormalities reported by 44% of people older than 40 on ART: results from REPRIEVE study

Post navigation